Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 18 July 1986:
Vol. 233. no. 4761, pp. 356 - 359
DOI: 10.1126/science.3726533

Articles

Science, Vol 233, Issue 4761, 356-359
Copyright © 1986 by American Association for the Advancement of Science


articles

Interferon inhibits the establishment of competence in Go/S-phase transition

SL Lin, T Kikuchi, WJ Pledger, and I Tamm

Addition of mouse interferon-alpha/beta (IFN) to confluent, quiescent BALB/c 3T3 (clone A31) mouse fibroblasts resulted in a block or delay in serum-induced activation of the cell cycle. It was necessary to add IFN within 6 hours after serum stimulation to inhibit nuclear labeling with [3H]thymidine. This is consistent with the time required for platelet-derived growth factor (PDGF) to induce cells to become competent to respond to additional growth factors present in platelet-poor plasma. Simultaneous addition of IFN with PDGF inhibited the PDGF-induced synthesis of a 29-kilodalton and a 35-kilodalton protein that normally occurs within 1 hour after PDGF addition. IFN also suppressed the general increase in protein synthesis that occurs by the fifth hour after PDGF addition. These results show that IFN antagonizes the action of PDGF, thereby interfering with the activation of Go cells for G1 traverse and S-phase entry.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Linear Signal Transduction Pathway Involving Phosphatidylinositol 3-Kinase, Protein Kinase C{epsilon}, and MAPK in Mesangial Cells Regulates Interferon-{gamma}-induced STAT1{alpha} Transcriptional Activation.
G. G. Choudhury (2004)
J. Biol. Chem. 279, 27399-27409
   Abstract »    Full Text »    PDF »
Potential Roles of Stat1 and Stat3 in Cellular Transformation.
J.F. BROMBERG and J.E. DARNELL Jr. (1999)
Cold Spring Harb Symp Quant Biol 64, 425-428
   Abstract »    PDF »
Stat3 Activation Is Required for Cellular Transformation by v-src.
J. F. Bromberg, C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell Jr. (1998)
Mol. Cell. Biol. 18, 2553-2558
   Abstract »    Full Text »
New Advances in Interferon Therapy of Cancer.
S. Wadler and E. L. Schwartz (1997)
Oncologist 2, 254-267
   Abstract »    Full Text »    PDF »
Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin.
D Jaskulski, J. deRiel, W. Mercer, B Calabretta, and R Baserga (1988)
Science 240, 1544-1546
   Abstract »    PDF »
Persistence and Expression of Human Papillomavirus During Interferon Therapy.
B. M. Steinberg, T. Gallagher, M. Stoler, and A. L. Abramson (1988)
Arch Otolaryngol Head Neck Surg 114, 27-32
   Abstract »    PDF »
Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes.
T. Ouchi, S. W. Lee, M. Ouchi, S. A. Aaronson, and C. M. Horvath (2000)
PNAS 97, 5208-5213
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)